SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹5.21 Cr | ₹4.97 Cr | - | - |
What is the latest Contingent Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹5.21 Cr |
| Mar2024 | ₹4.97 Cr |
| Mar2020 | - |
| Mar2019 | - |
How is Contingent Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.21 Cr | 4.87 | |
| Mar2024 | ₹4.97 Cr | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Contingent Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹826.9 Cr | -1.3% | -1.1% | 5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -1.3% |
-1.1% |
5.6% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses